Coloplast B A/S
Coloplast B A/S
-0,58 %
651,20 DKK
-3,80
Kurs
651,20
Høj
660,40
Ændring
-0,58 %
Lav
650,80
Opdateret
21-09-2018
Åben
656,00
Nyheder om Coloplast B A/S
Factsheet for Coloplast B A/S
Company Profile
Description
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy-care systems, disposable containment devices, paste, powder, seals, and wipes. Coloplast also maintains a tertiary presence in the urology and wound-care markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 66% of sales from Europe, 20% from North and South America, and 14% from the rest of the world.
Key Stats
Website: http://www.coloplast.com
Headquarter country: Denmark
Employees: 8.000
Market Cap (at close 21-09-2018): DKK 139B
Fiscal Year Ends: september
Stats

Stats 2017 2016 2015 2014 2013
Price/Earnings 27,60 32,20 132,60 46,30 28,50
Forward Price/Earnings 26,10 25,40 32,10 32,40 23,10
Price/Free Cash Flow 40,90 42,50 43,80 42,30 28,70
Return on Assets 32,90 28,80 8,50 24,20 27,70
Return on Equity 68,90 64,30 16,40 36,60 42,30
Return on Invested Capital 59,30 62,00 16,00 35,60 38,40
Dividend


Dividend/Share:13,50
Ex. Dividend Date:30-09-2017
Trailing Dividend Yield:2,37
Payout Ratio:86,35
Date Currency Amount
30-06-2018 DKK 5,00
31-12-2017 DKK 10,50
30-06-2017 DKK 4,50
31-12-2016 DKK 9,00
30-06-2016 DKK 4,50
31-12-2015 DKK 8,00
Income Statement

Revenue 2017 2016 2015 2014 2013
Total Revenue 15.528 14.681 13.909 12.428 11.635
Gross Profit 10,57 10,03 9,53 8,54 7,87
Gross Margin % 68,08% 68,33% 68,54% 68,70% 67,61%
Operating Expenses 2017 2016 2015 2014 2013
EBITDA 5.573,00 4.619,00 1.735,00 3.620,00 4.162,00
Net income 3.797,00 3.143,00 899,00 2.390,00 2.711,00
Basic Earnings Per Share 17,91 14,80 4,30 11,30 12,90
Operating Income 5,02 4,85 4,54 4,15 3,67
Operating Margin % 32,35% 33,01% 32,60% 33,37% 31,56%
Cash Flow

Cash Flow 2017 2016 2015 2014 2013
Operating Cash Flow 3.251,00 3.028,00 3.337,00 3.149,00 3.136,00
Capital Expenditures -685,00 -649,00 -617,00 -533,00 -440,00
Free Cash Flow 2.566,00 2.379,00 2.720,00 2.616,00 2.696,00
Balance Sheet

Assets 31-12-2017 31-12-2016 31-12-2015 31-12-2014 31-12-2013
Current Assets
Long Term Assets
Total Assets
Liabilities 31-12-2017 31-12-2016 31-12-2015 31-12-2014 31-12-2013
Total Current Liabilities
Long Term Liabilities
Total Liabilities
Equity 31-12-2017 31-12-2016 31-12-2015 31-12-2014 31-12-2013
Retained Earnings
Treasury Stock
Total Stockholder Equity
Net Tangible Assets